322 related articles for article (PubMed ID: 7954456)
21. PDGF-D is a potent transforming and angiogenic growth factor.
Li H; Fredriksson L; Li X; Eriksson U
Oncogene; 2003 Mar; 22(10):1501-10. PubMed ID: 12629513
[TBL] [Abstract][Full Text] [Related]
22. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH
Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294
[TBL] [Abstract][Full Text] [Related]
23. Flk-1 as a target for tumor growth inhibition.
Strawn LM; McMahon G; App H; Schreck R; Kuchler WR; Longhi MP; Hui TH; Tang C; Levitzki A; Gazit A; Chen I; Keri G; Orfi L; Risau W; Flamme I; Ullrich A; Hirth KP; Shawver LK
Cancer Res; 1996 Aug; 56(15):3540-5. PubMed ID: 8758924
[TBL] [Abstract][Full Text] [Related]
24. Control of PDGF-induced reactive oxygen species (ROS) generation and signal transduction in human lens epithelial cells.
Chen KC; Zhou Y; Zhang W; Lou MF
Mol Vis; 2007 Mar; 13():374-87. PubMed ID: 17392688
[TBL] [Abstract][Full Text] [Related]
25. Pregnancy-stimulated growth of vascular smooth muscle cells: importance of protein kinase C-dependent synergy between estrogen and platelet-derived growth factor.
Keyes LE; Moore LG; Walchak SJ; Dempsey EC
J Cell Physiol; 1996 Jan; 166(1):22-32. PubMed ID: 8557771
[TBL] [Abstract][Full Text] [Related]
26. Platelet derived growth factor/tyrosine kinase receptor mediated proliferation.
Benito M; Lorenzo M
Growth Regul; 1993 Sep; 3(3):172-9. PubMed ID: 8220110
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms through which gangliosides inhibit PDGF-stimulated mitogenesis in intact Swiss 3T3 cells: receptor tyrosine phosphorylation, intracellular calcium, and receptor binding.
Yates AJ; VanBrocklyn J; Saqr HE; Guan Z; Stokes BT; O'Dorisio MS
Exp Cell Res; 1993 Jan; 204(1):38-45. PubMed ID: 8416794
[TBL] [Abstract][Full Text] [Related]
28. Selective inhibition of platelet-derived growth factor (PDGF) receptor autophosphorylation and PDGF-mediated cellular events by a quinoline derivative.
Yagi M; Kato S; Kobayashi Y; Kubo K; Oyama S; Shimizu T; Nishitoba T; Isoe T; Nakamura K; Ohashi H; Kobayashi N; Iinuma N; Osawa T; Onose R; Osada H
Exp Cell Res; 1997 Aug; 234(2):285-92. PubMed ID: 9260896
[TBL] [Abstract][Full Text] [Related]
29. Limited selectivity of a synthetic erbstatin derivative for tyrosine kinase and cell growth inhibition.
Treuner M; Böhmer FD; Schulze W; Petuchov SP; Grosse R
Biochem Int; 1992 Mar; 26(4):617-25. PubMed ID: 1319149
[TBL] [Abstract][Full Text] [Related]
30. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
Brunton VG; Carlin S; Workman P
Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
[TBL] [Abstract][Full Text] [Related]
31. Expression of platelet-derived growth factor-independent phenotypes in BALB/c 3T3 cell variant with high susceptibility to chemically or physically induced neoplastic cell transformation: dissociation from activation of protein kinase C.
Tatsuka M; Owada MK; Mitsui H
Cancer Res; 1992 Aug; 52(15):4232-41. PubMed ID: 1638537
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antiproliferative activity of tyrphostins containing heteroaromatic moieties.
Brunton VG; Lear MJ; Robins DJ; Williamson S; Workman P
Anticancer Drug Des; 1994 Aug; 9(4):291-309. PubMed ID: 7916898
[TBL] [Abstract][Full Text] [Related]
33. PDGF induces c-myc mRNA expression in MG-63 human osteosarcoma cells but does not stimulate cell replication.
Womer RB; Frick K; Mitchell CD; Ross AH; Bishayee S; Scher CD
J Cell Physiol; 1987 Jul; 132(1):65-72. PubMed ID: 2439522
[TBL] [Abstract][Full Text] [Related]
34. The degree of inhibition of protein tyrosine kinase activity by tyrphostin 23 and 25 is related to their instability.
Ramdas L; McMurray JS; Budde RJ
Cancer Res; 1994 Feb; 54(4):867-9. PubMed ID: 7508821
[TBL] [Abstract][Full Text] [Related]
35. Alterations of the cytoskeletal organization in tumor cell lines by a cardiotonic drug, vesnarinone, through protein tyrosine phosphorylation.
Yoshinaka Y; Katoh I; Kyushiki H; Sakamoto Y
Exp Cell Res; 1995 Jul; 219(1):21-8. PubMed ID: 7543053
[TBL] [Abstract][Full Text] [Related]
36. Recombinant interferon-gamma inhibits the mitogenic effect of platelet-derived growth factor at a level distal to the growth factor receptor.
Hosang M
J Cell Physiol; 1988 Mar; 134(3):396-404. PubMed ID: 2832421
[TBL] [Abstract][Full Text] [Related]
37. Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells.
Bilder GE; Krawiec JA; McVety K; Gazit A; Gilon C; Lyall R; Zilberstein A; Levitzki A; Perrone MH; Schreiber AB
Am J Physiol; 1991 Apr; 260(4 Pt 1):C721-30. PubMed ID: 1850195
[TBL] [Abstract][Full Text] [Related]
38. Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats.
Rice AB; Moomaw CR; Morgan DL; Bonner JC
Am J Pathol; 1999 Jul; 155(1):213-21. PubMed ID: 10393853
[TBL] [Abstract][Full Text] [Related]
39. Platelet-derived growth factor: roles in normal and v-sis transformed cells.
Deuel TF; Kimura A; Maehama S; Tong BD
Cancer Surv; 1985; 4(4):633-53. PubMed ID: 2824043
[TBL] [Abstract][Full Text] [Related]
40. Platelet-derived growth factor receptor tyrosine kinase inhibitor AG1295 attenuates rat hepatic stellate cell growth.
Iwamoto H; Nakamuta M; Tada S; Sugimoto R; Enjoji M; Nawata H
J Lab Clin Med; 2000 May; 135(5):406-12. PubMed ID: 10811056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]